TruLeaf Medical, a medical device startup company, developing a breakthrough solution for transcatheter mitral valve replacement.
TruLeaf Medical was founded in 2017 by the late Prof. Uri Rosenschein, Netanel Benichou and Benjamin Spenser, who bring vast experience in structural heart disease, valve design and startup company management.
Our mission is to bring an ultimately user-friendly, Transcatheter Mitral Valve Replacement (TMVR) solution that will be available to every cardiologist and every Mitral Regurgitation (MR) patient. Our focus is on procedure simplicity, safety and efficacy.
TruLeaf's approach will bring the solution for the long-lasting problem in an elegant and safe way.
We aim for FIH trial Q4-2022.